HIM
NBRV

Hillhouse Investment Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Hillhouse Investment Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,863
Closed -$2.49M – 63
2018
Q2 		$2.49M Sell
2,863
-346
-11% -$396K 0.04% 52
2018
Q1 		$4.04M Hold
3,209
– – 0.07% 45
2017
Q4 		$4.8M Hold
3,209
– – 0.08% 42
2017
Q3 		$6.57M Buy
3,209
+463
+17% +$1.09M 0.11% 42
2017
Q2 		$7.19M Sell
2,746
-2
-0.1% -$5.16K 0.11% 43
2017
Q1 		$8.24M Sell
2,748
-52
-2% -$126K 0.16% 33
2016
Q4 		$4.17M Buy
+2,800
New +$3.72M 0.09% 28

Other funds holding NBRV

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Hillhouse Investment Management's NBRV Position: Q3 2018 in Review

Hillhouse Investment Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2018, closing a stake of 2,863 shares — an estimated $2.49M sold.

Hillhouse Investment Management first reported a position in NBRV in Q4 2016 and held it in 7 quarters. The position peaked at $8.24M in Q1 2017. 45 funds tracked by Wall St. Rank hold NBRV as of Q3 2018.

  • Hillhouse Investment Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2018 after selling out during the quarter.
  • Hillhouse Investment Management sold 2,863 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2018, an estimated $2.49M.
  • Hillhouse Investment Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2016 and held it in 7 quarters.
  • Hillhouse Investment Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $8.24M in Q1 2017.
  • 45 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2018.

Based on Hillhouse Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.